These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 6921128
1. [CEA and the clinical course in advanced carcinoma of the uterine cervix (author's transl)]. Braun P, Leyendecker G. Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):462-7. PubMed ID: 6921128 [Abstract] [Full Text] [Related]
2. [Clinical evaluation of serum CEA levels in uterine cervix cancer]. Kikuchi Y, Hirose J, Uekita Y, Hayasaka K, Asano A, Nishino S, Mitsuhashi H, Amo K, Washizuka N, Mure I, Yamashita Y. Gan No Rinsho; 1983 Apr; 29(4):A-21, 330-5. PubMed ID: 6854968 [Abstract] [Full Text] [Related]
3. [Carcinoembryonic antigen in carcinoma of the uterine cervix. Correlations with clinical stage, histopathology, and survival about 115 cases (author's transl)]. Bolla M, Vrousos C, Horiot JC, Guerrin J, Bordes M, Le Dorze C. Pathol Biol (Paris); 1979 Dec; 27(10):611-4. PubMed ID: 395491 [Abstract] [Full Text] [Related]
4. Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress. DiSaia PJ, Morrow CP, Haverback BJ, Dyce BJ. Obstet Gynecol; 1976 Jan; 47(1):95-9. PubMed ID: 1246404 [Abstract] [Full Text] [Related]
5. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ. Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143 [Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen in cervical cancer: a five-year follow-up. Braun P, Leyendecker G. Cancer Detect Prev; 1983 Mar; 6(1-2):249-53. PubMed ID: 6883384 [Abstract] [Full Text] [Related]
7. [Carcino-embryonic antigen in cases of cervical carcinoma (author's transl)]. Weppelmann B, Schulz BO, Oberheuser F. Zentralbl Gynakol; 1981 Mar; 103(21):1273-9. PubMed ID: 6275635 [Abstract] [Full Text] [Related]
8. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix]. Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y. Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418 [Abstract] [Full Text] [Related]
9. [Carcinoembryonic antigen in carcinoma of the uterine cervix (author's transl)]. Bolla M, Vrousos C, Horiot JC, Bordes M, Le Dorze C. Bull Cancer; 1979 Jan; 66(5):525-9. PubMed ID: 554680 [Abstract] [Full Text] [Related]
10. [Carcino-embryonic-antigen (CEA) in adenocarcinoma of uterine corpus (author's transl)]. Weppelmann B, Oberheuser F. Zentralbl Gynakol; 1979 Jan; 101(15):945-9. PubMed ID: 532418 [Abstract] [Full Text] [Related]
11. [Clinical evaluation of serum CEA levels in uterine cervix cancer patients with radiotherapy]. Takahashi K, Kikuchi Y, Nishino S, Asano A, Arakawa K, Yoshikawa H, Hayasaka K, Amoh K, Uekita Y. Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep 25; 44(9):1172-80. PubMed ID: 6522269 [No Abstract] [Full Text] [Related]
12. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)]. Anger H, Gleissenberger U. Geburtshilfe Frauenheilkd; 1977 Jul 25; 37(7):604-8. PubMed ID: 885332 [Abstract] [Full Text] [Related]
13. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan 25; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
14. The role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervix. Tsai CC, Lin H, Huang EY, Huang SC, Hsieh CH, Chang SY, Chien CC. Gynecol Oncol; 2004 Aug 25; 94(2):363-7. PubMed ID: 15297173 [Abstract] [Full Text] [Related]
15. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, Suzuki K, Uno T, Tokumaru S, Takayama M, Sekiguchi K, Matsumoto Y, Michimoto K, Oguchi M, Hayakawa K. Gynecol Oncol; 2006 Nov 25; 103(2):435-8. PubMed ID: 16677691 [Abstract] [Full Text] [Related]
16. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW. Obstet Gynecol; 1989 Apr 25; 73(4):661-8. PubMed ID: 2648225 [Abstract] [Full Text] [Related]
17. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix]. Ma SK, Wu LY, Sun YC, Li B, Zhang HT. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 25; 43(1):13-7. PubMed ID: 18366925 [Abstract] [Full Text] [Related]
18. [The monitoring of gynecological radiotherapy using serial tumor marker determinations]. Wagner RK, Atzinger A, Breit A. Strahlenther Onkol; 1990 Jul 25; 166(7):446-52. PubMed ID: 2200151 [Abstract] [Full Text] [Related]
19. [Serum ferritin levels in patient with gynecological malignancy--especially the judgement of therapeutic response and the monitor during the post-therapeutic follow-up period (author's transl)]. Washizuka N, Yamazaki T, Shimizu T, Kikuchi Y. Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct 25; 33(10):1695-702. PubMed ID: 7310197 [Abstract] [Full Text] [Related]